Structural analysis between arsenic and CYP2C8 enzyme interaction by docking

被引：0
|
作者：
Rangel Lopez, A. [1 ,2 ]
Nieto Delgado, G. [2 ]
Vertiz Hernandez, A. [1 ,2 ]
Terrones Gurrola, R. [1 ,2 ]
机构：
[1] Univ Autonoma San Luis Potosi, Matehuala, Mexico
[2] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [21] CYP2C8 Exists as a Dimer in Natural Membranes
    Hu, Gang
    Johnson, Eric F.
    Kemper, Byron
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (11) : 1976 - 1983
  • [22] CYP2C8 polymorphism impacts amodiaquine metabolism
    不详
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (05) : 339 - 339
  • [23] Selexipag contraindicated with strong CYP2C8 inhibitors
    Reactions Weekly, 2017, 1658 (1) : 6 - 6
  • [24] Functional characterization of CYP2C8 promoter polymorphisms
    Selvarajan, V.
    EJC SUPPLEMENTS, 2009, 7 (04): : 29 - 29
  • [25] Tucatinib inhibits CYP3A, CYP2C8 and P-gp-mediated elimination and is impacted by CYP2C8 inhibition in healthy volunteers
    Topletz-Erickson, Ariel R.
    Lee, Anthony
    Sun, Hao
    Mayor, JoAl
    Walker, Luke
    Endres, Christopher J.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] RIVOGLITAZONE (CS-011) PHARMACOKINETICS ARE AFFECTED BY COADMINSTRATION OF THE POTENT CYP2C8 INHIBITOR GEMBROZIL BUT NOT CYP2C8 GENOTYPES.
    Wickremasingha, P. K.
    Mendell, J.
    He, L.
    Mun, Y.
    Izumi, T.
    Allison, M. J.
    Walker, J. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S48 - S48
  • [27] Induction of CYP2C8 by rifampicin is mediated via a novel pregnane X receptor (PXR) binding site in the CYP2C8 promoter
    Ferguson, SS
    LeCluyse, E
    Negishi, M
    Goldstein, J
    DRUG METABOLISM REVIEWS, 2002, 34 : 111 - 111
  • [28] INHIBITORY EFFECT OF SIX COMMONLY USED HERBAL EXTRACTS ON CYP2C8 ENZYME ACTIVITY
    Albassam, A. A.
    Frye, R. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S35 - S35
  • [29] Novel CYP2C8 haplotypes of functional importance
    Rodriguez-Antona, C
    Ingelman-Sundberg, A
    DRUG METABOLISM REVIEWS, 2005, 37 : 22 - 23
  • [30] Response and neurologic toxicity to taxano regarding to CYP2C8*3 and CYP2C8*2 polymorphisms in Peruvian breast cancer cases.
    Alcarraz, Cindy
    Altamirano, Carlos Castaneda
    Gomez, Henry
    Zavaleta, Amparo
    Flores, Carol
    Garcia, Miluska Castillo
    Cerna, Ketty Dolores
    Saba, Julio E. Abugattas
    Vidaurre, Tatiana
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345